Weeks 25 through 52 and beyond transition into maintenance weight loss and body composition refinement
GLP-1 RAs can have some side effects, which are mostly related to the digestive system
Regenerative PerformancePhysician-ordered, physician-supervised
Liepinsh E, Makrecka-Kuka M, Makarova E, Volska K, Svalbe B, Sevostjanovs E, et al
If larger trials confirm the early results, CagriSema may offer deeper weight loss for people who previously struggled on single-agent therapies
Most cases of primary MCAS manifest with cutaneous or systemic mastocytosis, with symptoms including skin rashes, hives, abdominal pain, and anaphylaxis